422 related articles for article (PubMed ID: 33525620)
1. T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine.
Schmidt A; Lapuente D
Viruses; 2021 Jan; 13(2):. PubMed ID: 33525620
[TBL] [Abstract][Full Text] [Related]
2. Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine.
Tchilian E; Holzer B
Viruses; 2017 May; 9(5):. PubMed ID: 28475122
[TBL] [Abstract][Full Text] [Related]
3. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
[TBL] [Abstract][Full Text] [Related]
4. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.
Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM
J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033
[TBL] [Abstract][Full Text] [Related]
5. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
6. IL-1β as mucosal vaccine adjuvant: the specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses.
Lapuente D; Storcksdieck Genannt Bonsmann M; Maaske A; Stab V; Heinecke V; Watzstedt K; Heß R; Westendorf AM; Bayer W; Ehrhardt C; Tenbusch M
Mucosal Immunol; 2018 Jul; 11(4):1265-1278. PubMed ID: 29545648
[TBL] [Abstract][Full Text] [Related]
7. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
[TBL] [Abstract][Full Text] [Related]
8. Epigraph hemagglutinin vaccine induces broad cross-reactive immunity against swine H3 influenza virus.
Bullard BL; Corder BN; DeBeauchamp J; Rubrum A; Korber B; Webby RJ; Weaver EA
Nat Commun; 2021 Feb; 12(1):1203. PubMed ID: 33619277
[TBL] [Abstract][Full Text] [Related]
9. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
[TBL] [Abstract][Full Text] [Related]
10. Influenza and Antibody-Dependent Cellular Cytotoxicity.
Von Holle TA; Moody MA
Front Immunol; 2019; 10():1457. PubMed ID: 31316510
[TBL] [Abstract][Full Text] [Related]
11. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
Dong W; Bhide Y; Sicca F; Meijerhof T; Guilfoyle K; Engelhardt OG; Boon L; de Haan CAM; Carnell G; Temperton N; de Vries-Idema J; Kelvin D; Huckriede A
Front Immunol; 2018; 9():2312. PubMed ID: 30356772
[TBL] [Abstract][Full Text] [Related]
12. Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.
Lee YN; Kim MC; Lee YT; Kim YJ; Lee J; Kim C; Ha SH; Kang SM
Antiviral Res; 2015 Oct; 122():82-90. PubMed ID: 26248203
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
14. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
15. How far have we reached in development of effective influenza vaccine?
Looi QH; Foo JB; Lim MT; Le CF; Show PL
Int Rev Immunol; 2018; 37(5):266-276. PubMed ID: 30252547
[TBL] [Abstract][Full Text] [Related]
16. MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.
Testa JS; Shetty V; Hafner J; Nickens Z; Kamal S; Sinnathamby G; Philip R
PLoS One; 2012; 7(11):e48484. PubMed ID: 23144892
[TBL] [Abstract][Full Text] [Related]
17. Return of inactivated whole-virus vaccine for superior efficacy.
Furuya Y
Immunol Cell Biol; 2012 Jul; 90(6):571-8. PubMed ID: 21844883
[TBL] [Abstract][Full Text] [Related]
18. Harnessing Cross-Reactive CD8
Uddbäck I; Kohlmeier JE; Thomsen AR; Christensen JP
Viral Immunol; 2020 Apr; 33(3):201-207. PubMed ID: 32286174
[No Abstract] [Full Text] [Related]
19. Development of an Alternative Modified Live Influenza B Virus Vaccine.
Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
[TBL] [Abstract][Full Text] [Related]
20. Memory T Cell Dynamics in the Lung during Influenza Virus Infection.
Pizzolla A; Wakim LM
J Immunol; 2019 Jan; 202(2):374-381. PubMed ID: 30617119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
